Skip to content

Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology

Home
Uncategorized
Galmed Pharmaceuticals receives Nasdaq bid price deficiency notice

Galmed Pharmaceuticals receives Nasdaq bid price deficiency notice

Jan 30, 2026

Post navigation

Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification

Olema Oncology announces departure of chief operating and financial officer

PR Newswire
GlobeNewswire

Contact
Privacy Policy

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Search for: